Artificial Organs Market Size By Organ Type (Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas, Artificial Heart), By Material Type (Silicon, Plastic, Steel), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Oct 2020  |  Report ID: GMI3447  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 101   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry trends

Artificial Organs Market size valued at USD 18 billion in 2019 and is estimated to grow at over 8.9% CAGR from 2020 to 2026. Manufacturers and researchers are continuously focusing on development of artificial organs to improve its chances of acceptance by the receiver. Innovation in artificial organs delivers equally effective treatment solutions to patients that do not qualify for conventional organ transplants. Technological advancements in production process such as bioartificial organ manufacturing, standardization and automation will further stimulate the industry growth.
 

Artificial Organs Market

Get more details on this report - Request Free Sample PDF
 

Artificial organs reduce probability of organ rejection and provides advantage of mass production. According to the American Transplant Foundation, about 114,000 people are in the waiting list for organ transplantation and approximately 20 people die due to unavailability of organs. With such increasing demand for the organ transplants, the market will witness significant growth as artificial organs help minimize donor organ’s dearth.
 

Product innovations aiming to manage drawback of organ scarcity

Rising cases of organ failure owing to severe sepsis, cardiovascular diseases and trauma incidence drives the number of organ transplant procedures. According to the World Health Organization, about 48.9 million sepsis cases were estimated in 2017. Changing lifestyle and adoption of unhealthy habits such as alcohol consumption and smoking result into liver and heart failure. With growing prevalence of such conditions, the risk of organ dysfunction also increases that will ultimately boost the market demand.
 

Technological advancements will primarily propel the artificial organs market growth in coming years. The BiVACOR has developed total artificial heart (TAH) device providing innovative option to with end-stage heart failure patients that are unable to qualify for transplants. In addition, SynCardia Systems has introduced temporary implantable total artificial heart device that can perform heart functions for patients with end-stage biventricular heart failure. Thus, launch of advanced innovative products offering beneficial solutions will offer immense opportunities for market expansion.
 

However, risk associated with organ rejection and significant cost associated with artificial organs can hamper the product demand up to some extent.
 

Artificial Organs Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: USD 18.6 Billion
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 8.9% 2026 Value Projection: USD 33.7 Billion
Pages: 101 Tables, Charts & Figures: 146
Geographies covered (19): U.S., Canada, UK, France, Germany, Spain, Italy, Russia, Poland, Turkey, China, India, Japan, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia
Segments covered: Organ Type, Material Type
Companies covered (10): Medtronic Plc, Berlin Heart GmbH (Syscore GmbH), Boston Scientific Corporation, Ekso Bionics Holdings, Inc., Zimmer Biomet, Baxter, Cochlear Ltd., Nipro Corporation, Ottobock, SynCardia Systems, LLC
Growth Drivers:
  • Scarcity of organ donors globally
  • Increasing incidence of organ failures
  • Growing technological advancements
Pitfalls & Challenges:
  • Product failure after transplantation
  • High cost of artificial organs
  • Rising prevalence of infections due to material used for artificial organ development

Get more details on this report - Request Free Sample PDF
 

Improving success rates of total artificial hearts with technological developments will stimulate the market value

Artificial heart market will showcase growth of around 9.7% till 2026. Since last few years, there has been significant increase in total artificial heart implantations. Moreover, advancements including organ development with stem cells and 3D printed hearts will increase its adoption among patients.
 

According to the Centres for Disease Control and Prevention, about 6.2 million adults suffer through heart failure. Although several non-profit and government organizations are undertaking awareness initiatives regarding organ donation, significantly rising number of heart failures creates organ scarcity resulting into untreated conditions and deaths. Advantage of artificial hearts to increase life-saving treatment accessibility will impact its revenue.  
       

Enhanced product quality and biocompatibility with use of polymers will augment the product demand

Plastic artificial organs market accounted for more than 22% share in 2019 led by its advantages including biocompatibility and cost-effectivity in manufacturing. With wide adoption of high polymers in artificial organ replacement, the segment will continue to observe growth during the forecast timeline.
 

Rising incidence of organ failure leading to increase in organ transplant procedures in the European region

Europe Artificial Organs Market

Get more details on this report - Request Free Sample PDF
 

Europe artificial organs market held over 25% of revenue share in 2019. During 2019, about 150,000 registrations were reported on organ waiting lists in the region, according to the European registry. Approximately, 41,000 organ transplantations occur every year and 48,000 new registrations are added on the waiting list. Growing burden of heart disease, end-stage kidney and lung disorders will thus continue to provide demand for artificial organs in European countries.
 

Prominent industry players are focusing on product innovations

Some of the prominent business participants operating in the artificial organs market include Medtronic Plc., Ekso Bionics Holdings, Inc., Baxter, Cochlear and Boston Scientific Corporation. These leaders are adopting various inorganic growth strategies to gain market share and sustainable competitive advantage.
 

Some of the recent industry developments:

  • In November 2019, Baxter and Ayogo Health Inc. announced CKD&me application in field Of Nephrology. This app helped company to enter digital diagnostic market that will generate revenue and attract the home device users, physicians for easy analysis.
     
  • In September 2019, Zimmer Biomet received FDA clearance for Juggerstitch meniscal repair device. The product provides a less invasive solution for meniscal repair treatment. This has offered business expansion opportunities to the firm.
     
  • In June 2018, Medtronic received CE mark for the MiniMed 670G system. The system delivers personalized and automated dosage of basal insulin. This approval helped the company to market their products in European countries and provided lucrative opportunities to increase their revenue generation.
     

This market research report on artificial organs includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

Market, By Organ Type

  • Artificial Kidney
  • Artificial Liver
  • Artificial Lungs
  • Artificial Pancreas
  • Artificial Heart
  • Others

Market, By Material Type

  • Silicon
  • Plastic
  • Steel
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Poland
    • Turkey
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
       

Frequently Asked Questions (FAQ) :

Global artificial organs market size is likely to grow at 8.9% CAGR through 2026, having recorded USD 18 billion in 2019, driven by efforts by researchers on innovative development of artificial organs to enhance their acceptance chances.
Artificial heart segment will witness 9.7% CAGR through 2026, propelled by massive increase in the number of artificial heart implantations.
Plastic segment held 22% market share and will depict appreciable growth as the material has several advantages such as cost-effectivity in manufacturing and biocompatibility.
Europe accounted for 25% of the artificial organs industry share and will depict massive growth driven by rising burden of heart disease and lung disorders.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Oct 2020
  • Pages: 101
  • Tables: 135
  • Charts / Figures: 11
  • Companies covered: 10
  • Countries covered: 19

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X